tradingkey.logo

Autonomix Medical Inc

AMIX

1.060USD

+0.010+0.95%
Close 09/19, 16:00ETQuotes delayed by 15 min
4.26MMarket Cap
LossP/E TTM

Autonomix Medical Inc

1.060

+0.010+0.95%
More Details of Autonomix Medical Inc Company
Autonomix Medical, Inc. is a medical device company, which is focused on advancing technologies to treat diseases involving the peripheral nervous system. Its technology platform includes a catheter-based microchip sensing array that has the ability to detect and differentiate peripheral neural signals with up to 1,000 times sensitivity. It is developing a two-fold technology that can both detect malfunctioning neural signals and ablate nerves in one simple procedure for pain management. It is developing its technology for pancreatic cancer and pancreatitis, conditions that can cause debilitating pain and need an effective solution. Its technology constitutes a platform with the potential to address dozens of indications, including in cardiology, renal denervation, and chronic pain management across a disease spectrum. Its Autonomix catheter is equipped with a microchip that converts analog signals from the body to a digital signal that can be sent directly to a computer screen.
Company Info
Ticker SymbolAMIX
Company nameAutonomix Medical Inc
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Number of employees8
Security typeOrdinary Share
Fiscal year-endJan 29
Address21 Waterway Ave, Suite 300
CityTHE WOODLANDS
Stock exchangeNASDAQ Capital Market Consolidated
CountryUnited States of America
Postal code77380
Phone18322777816
Websitehttps://autonomix.com/
Ticker SymbolAMIX
IPO dateJan 29, 2024
CEOMr. Bradley (Brad) Hauser
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
-2.12%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
-8.42%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
-68.52%
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Ms. Lori H. Bisson
Ms. Lori H. Bisson
Executive Vice Chairman of the Board
Executive Vice Chairman of the Board
--
--
Mr. Jonathan P. Foster
Mr. Jonathan P. Foster
Independent Director
Independent Director
--
--
Mr. David Andrew Robins
Mr. David Andrew Robins
Independent Director
Independent Director
--
-100.00%
Ms. Jenene Thomas
Ms. Jenene Thomas
Investor Relations
Investor Relations
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Landy Toth
Mr. Landy Toth
Chief Technology Officer
Chief Technology Officer
101.31K
-2.12%
Mr. Robert Schwartz
Mr. Robert Schwartz
Chief Medical Officer
Chief Medical Officer
35.77K
-8.42%
Mr. Bradley (Brad) Hauser
Mr. Bradley (Brad) Hauser
President, Chief Executive Officer
President, Chief Executive Officer
11.25K
--
Mr. Trent N. Smith
Mr. Trent N. Smith
Chief Financial Officer
Chief Financial Officer
3.75K
-68.52%
Dr. Christopher Capelli, M.D.
Dr. Christopher Capelli, M.D.
Independent Director
Independent Director
3.75K
--
Mr. Walter V. Klemp
Mr. Walter V. Klemp
Executive Chairman of the Board
Executive Chairman of the Board
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Sun, Sep 14
Updated: Sun, Sep 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Klemp (Walter V.)
2.54%
BioStar Ventures III, L.P.
2.03%
Heights Capital Management, Inc.
1.95%
Toth (Landy)
1.71%
Mariner Wealth Advisors
1.69%
Other
90.08%
Shareholders
Shareholders
Proportion
Klemp (Walter V.)
2.54%
BioStar Ventures III, L.P.
2.03%
Heights Capital Management, Inc.
1.95%
Toth (Landy)
1.71%
Mariner Wealth Advisors
1.69%
Other
90.08%
Shareholder Types
Shareholders
Proportion
Individual Investor
5.84%
Investment Advisor
4.12%
Corporation
2.03%
Hedge Fund
0.38%
Research Firm
0.29%
Investment Advisor/Hedge Fund
0.17%
Other
87.17%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
39
859.06K
17.01%
+144.42K
2025Q1
38
911.14K
32.77%
+69.62K
2024Q4
37
970.61K
39.41%
+334.04K
2024Q3
33
498.18K
43.25%
+16.51K
2024Q2
26
438.67K
42.98%
+436.93K
2024Q1
16
314.97K
29.85%
+314.97K
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Klemp (Walter V.)
150.75K
5.42%
--
--
Oct 25, 2024
BioStar Ventures III, L.P.
120.82K
4.35%
+1.00
+0.00%
Oct 25, 2024
Heights Capital Management, Inc.
116.09K
4.18%
-18.91K
-14.01%
Dec 31, 2024
Toth (Landy)
101.31K
3.64%
--
--
Oct 25, 2024
Mariner Wealth Advisors
100.64K
3.62%
+25.00
+0.02%
Mar 31, 2025
Foster (Jonathan P.)
36.56K
1.31%
--
--
Oct 25, 2024
Schwartz (Robert)
35.76K
1.29%
+1.00
+0.00%
Oct 25, 2024
Ikarian Capital LLC
20.00K
0.72%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Date
Type
Ratio
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
Oct 22, 2024
Merger
20→1
KeyAI